Aducanumab: A Deep Dive into BIIB037 and its Impact A drug, originally known as BIIB037, constitutes a significant endeavor to address early-stage Alzheimer's illness. Developed by Biogen, the treatment acts by https://lucqelx952390.blog-gold.com/58808512/text